[go: up one dir, main page]

WO2008025790A3 - Use of opioid formulations in needle-less drug delivery devices - Google Patents

Use of opioid formulations in needle-less drug delivery devices Download PDF

Info

Publication number
WO2008025790A3
WO2008025790A3 PCT/EP2007/058976 EP2007058976W WO2008025790A3 WO 2008025790 A3 WO2008025790 A3 WO 2008025790A3 EP 2007058976 W EP2007058976 W EP 2007058976W WO 2008025790 A3 WO2008025790 A3 WO 2008025790A3
Authority
WO
WIPO (PCT)
Prior art keywords
needle
drug delivery
less drug
opioid
delivery devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/058976
Other languages
French (fr)
Other versions
WO2008025790A2 (en
Inventor
Jo Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to JP2009526093A priority Critical patent/JP5306207B2/en
Priority to SI200731146T priority patent/SI2056825T1/en
Priority to US12/439,386 priority patent/US8987290B2/en
Priority to EP07802993A priority patent/EP2056825B1/en
Priority to ES07802993T priority patent/ES2398925T3/en
Priority to DK07802993.1T priority patent/DK2056825T3/en
Priority to PL07802993T priority patent/PL2056825T3/en
Publication of WO2008025790A2 publication Critical patent/WO2008025790A2/en
Publication of WO2008025790A3 publication Critical patent/WO2008025790A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The present invention concerns a needle- less drug delivery device being suitable for delivering drugs through a skin surface into a human or animal body comprising a pharmaceutical composition with at least one analgesic agent preferably being an opioid. The present invention also relates to the use of at least one analgesic agent, preferably being at least one opioid in a needle-less drug delivery device being suitable for injecting medication through a skin surface into the human or animal body. Further, the invention is concerned with a method of treating breakthrough pain by injecting at least one analgesic agent preferably being an opioid into the human or animal body using a needle- less drug delivery device.
PCT/EP2007/058976 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices Ceased WO2008025790A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2009526093A JP5306207B2 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-free drug delivery devices
SI200731146T SI2056825T1 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices
US12/439,386 US8987290B2 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices
EP07802993A EP2056825B1 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices
ES07802993T ES2398925T3 (en) 2006-08-29 2007-08-29 Use of opioid formulations in devices for needleless drug administration
DK07802993.1T DK2056825T3 (en) 2006-08-29 2007-08-29 APPLICATION OF OPIOID FORMULAS IN NEEDLE-FREE PHARMACEUTICAL SUPPLY DEVICES
PL07802993T PL2056825T3 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119722.4 2006-08-29
EP06119722 2006-08-29

Publications (2)

Publication Number Publication Date
WO2008025790A2 WO2008025790A2 (en) 2008-03-06
WO2008025790A3 true WO2008025790A3 (en) 2008-05-15

Family

ID=38089858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/058976 Ceased WO2008025790A2 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices

Country Status (11)

Country Link
US (1) US8987290B2 (en)
EP (1) EP2056825B1 (en)
JP (1) JP5306207B2 (en)
CY (1) CY1113575T1 (en)
DE (1) DE202006018609U1 (en)
DK (1) DK2056825T3 (en)
ES (1) ES2398925T3 (en)
PL (1) PL2056825T3 (en)
PT (1) PT2056825E (en)
SI (1) SI2056825T1 (en)
WO (1) WO2008025790A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846090B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US8932630B1 (en) 1997-12-22 2015-01-13 Purdue Pharma L.P Opioid agonist/antagonist combinations
US8969369B2 (en) 2001-05-11 2015-03-03 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9474750B2 (en) 1997-12-22 2016-10-25 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
AR075735A1 (en) 2009-03-10 2011-04-20 Euro Celtique Sa PHARMACEUTICAL COMPOSITIONS OF IMMEDIATE RELEASE THAT INCLUDE OXYCODONE AND NALOXONE. USE
US9504629B2 (en) * 2012-04-20 2016-11-29 Smiths Medical Asd, Inc. Medication dispensers
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
FR3032353B1 (en) 2015-02-06 2017-03-10 Jacques Seguin PHARMACEUTICAL COMPOSITION AND DEVICE FOR THE TREATMENT OF PAIN
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000013668A1 (en) * 1998-09-03 2000-03-16 Quadrant Healthcare (Uk) Limited Microparticles
WO2002047688A2 (en) * 2000-12-11 2002-06-20 Cephalon, Inc. Method and apparatus for treating breakthrough pain
WO2002051470A2 (en) * 2000-11-30 2002-07-04 Biovalve Technologies, Inc. Injection systems
US20040015126A1 (en) * 2000-03-03 2004-01-22 Bernd Zierenberg Needle-less injector of miniature type
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
EP1752174A1 (en) * 2005-08-10 2007-02-14 Alza Corporation Needle-free jet injection drug delivery device
WO2007149514A2 (en) * 2006-06-19 2007-12-27 Corium International, Inc. Methods, devices, and kits for microjet drug delivery

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735761A (en) * 1971-02-11 1973-05-29 Ampoules Inc Hypodermic devices
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
SE9201246D0 (en) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab INJECTION CARTRIDGE ARRANGEMENT
DE4445969C1 (en) * 1994-12-22 1996-03-14 Schott Glaswerke Syringe cylinder with two compartments for two constituents
US5730723A (en) * 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US6375957B1 (en) * 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
UA55507C2 (en) * 1997-12-22 2003-04-15 Еро-Селтік, С.А. Combination of opioid agonist / antagonist
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
DE10010123A1 (en) * 2000-03-03 2001-09-20 Boehringer Ingelheim Int Needle-less injector for liquids comprises a tensioning system, an energy storing spring, a hollow piston in a cylinder, and a nozzle
WO2002083215A1 (en) * 2001-04-13 2002-10-24 Becton Dickinson And Company Intradermal needle
CN1525851A (en) * 2001-05-11 2004-09-01 ������ҩ�����޹�˾ Abuse-resistant controlled-release opioid dosage form
JP2005508676A (en) 2001-08-17 2005-04-07 アンタレス・ファーマ・インコーポレーテッド Insulin administration with a jet syringe
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
GB2379390B (en) 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
DK2425821T5 (en) * 2002-04-05 2018-02-12 Mundipharma As Pharmaceutical preparation containing oxycodone and naloxone
DE102004042581B4 (en) * 2004-09-02 2022-09-15 Ypsomed Ag Auto-Pen for dual-chamber ampoule
EP1843812A4 (en) * 2005-02-01 2008-12-03 Intelliject Llc Devices, systems, and methods for medicament delivery
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000013668A1 (en) * 1998-09-03 2000-03-16 Quadrant Healthcare (Uk) Limited Microparticles
US20040015126A1 (en) * 2000-03-03 2004-01-22 Bernd Zierenberg Needle-less injector of miniature type
WO2002051470A2 (en) * 2000-11-30 2002-07-04 Biovalve Technologies, Inc. Injection systems
WO2002047688A2 (en) * 2000-12-11 2002-06-20 Cephalon, Inc. Method and apparatus for treating breakthrough pain
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
EP1752174A1 (en) * 2005-08-10 2007-02-14 Alza Corporation Needle-free jet injection drug delivery device
WO2007149514A2 (en) * 2006-06-19 2007-12-27 Corium International, Inc. Methods, devices, and kits for microjet drug delivery

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAER C L, BENNETT W M, FOLWICK D A, ERICKSON R S: "Effectiveness of a jet injection system in administering morphine and heparin to healthy adults", AM J CRIT CARE, vol. 5, no. 1, 1996, pages 42 - 48, XP008088675 *
RIPAMONTI ET AL: "Palliative medical management", EUROPEAN JOURNAL OF CANCER, SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 3, no. 3, October 2005 (2005-10-01), pages 203 - 219, XP005130012, ISSN: 1359-6349 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9474750B2 (en) 1997-12-22 2016-10-25 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations
US8932630B1 (en) 1997-12-22 2015-01-13 Purdue Pharma L.P Opioid agonist/antagonist combinations
US9205082B2 (en) 1997-12-22 2015-12-08 Purdue Pharma L.P. Opioid agonist/antagonist combinations
US8969369B2 (en) 2001-05-11 2015-03-03 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9161937B2 (en) 2001-05-11 2015-10-20 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9168252B2 (en) 2001-05-11 2015-10-27 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9283216B2 (en) 2001-05-11 2016-03-15 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9345701B1 (en) 2001-05-11 2016-05-24 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9480685B2 (en) 2001-05-11 2016-11-01 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9511066B2 (en) 2001-05-11 2016-12-06 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US8846091B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US8846090B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US9555000B2 (en) 2002-04-05 2017-01-31 Purdue Pharma L.P. Pharmaceutical preparation containing oxycodone and naloxone

Also Published As

Publication number Publication date
EP2056825A2 (en) 2009-05-13
PT2056825E (en) 2013-02-15
SI2056825T1 (en) 2013-06-28
US8987290B2 (en) 2015-03-24
DK2056825T3 (en) 2013-02-04
EP2056825B1 (en) 2012-11-14
WO2008025790A2 (en) 2008-03-06
PL2056825T3 (en) 2013-04-30
ES2398925T3 (en) 2013-03-22
JP2010501308A (en) 2010-01-21
DE202006018609U1 (en) 2007-05-16
JP5306207B2 (en) 2013-10-02
US20100056554A1 (en) 2010-03-04
CY1113575T1 (en) 2016-06-22

Similar Documents

Publication Publication Date Title
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
MX2009010000A (en) Drug delivery device.
WO2007098479A3 (en) Localized insulin delivery for bone healing
WO2008064192A3 (en) Modified release analgesic suspensions
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
EP2600930A4 (en) INJECTION APPARATUS AND METHOD FOR DELIVERY OF MEDICAMENT
MX2009009131A (en) Improvements in and relating to medicinal compositions.
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
WO2009129464A3 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
WO2009029958A3 (en) Implantable delivery device
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
BRPI0904961A2 (en) Implantable medical device, drug depot and method of administering a biologically active agent and clonidine or derivative thereof to a tissue and producing a drug depot
NZ592276A (en) PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(epsilon-CAPROLACTONE) AND AN OPIOID
WO2007005716A3 (en) Methods of treatment and compositions for use thereof
MX358492B (en) Slow intraventricular delivery.
MX2009009132A (en) Improved medicinal compositions comprising buprenorphine and naltrexone.
WO2005055921A3 (en) Compositions for treatment of ear disorders and methods of use thereof
WO2008011426A3 (en) Methods and medicaments for administration of ibuprofen
WO2008117268A3 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
WO2014036556A3 (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
MX2013012206A (en) Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof.
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07802993

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009526093

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007802993

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

WWE Wipo information: entry into national phase

Ref document number: 12439386

Country of ref document: US